Russell Investments Group
ALT icon

Russell Investments Group’s Altimmune ALT Stock Holding History

Russell Investments Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.6K Buy
16,092
+1,555
+11% +$6.6K ﹤0.01% 3332
2025
Q4 		$52.5K Buy
14,537
+608
+4% +$2.65K ﹤0.01% 3283
2025
Q3 		$52.5K Buy
13,929
+9,249
+198% +$35.7K ﹤0.01% 3276
2025
Q2 		$18.1K Buy
4,680
+476
+11% +$2.58K ﹤0.01% 3217
2025
Q1 		$21K Sell
4,204
-174
-4% -$1.1K ﹤0.01% 3101
2024
Q4 		$31.6K Hold
4,378
– – ﹤0.01% 2923
2024
Q3 		$26.9K Sell
4,378
-4,106
-48% -$27.8K ﹤0.01% 2898
2024
Q2 		$56.4K Buy
8,484
+4,107
+94% +$30.3K ﹤0.01% 2736
2024
Q1 		$44.6K Buy
4,377
+74
+2% +$753 ﹤0.01% 2680
2023
Q4 		$48.4K Buy
4,303
+3,959
+1,151% +$16.5K ﹤0.01% 2642
2023
Q3 		$894 Buy
+344
New +$987 ﹤0.01% 3351
2022
Q1 		– Sell
-27,000
Closed -$247K – 2740
2021
Q4 		$247K Buy
+27,000
New +$287K ﹤0.01% 2663
2017
Q3 		– Sell
-486
Closed -$47K – 2934
2017
Q2 		$47K Sell
486
-921
-65% -$153K ﹤0.01% 2888
2017
Q1 		$342K Buy
1,407
+694
+97% +$371K ﹤0.01% 2560
2016
Q4 		$695K Buy
+713
New +$639K ﹤0.01% 2347

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Russell Investments Group's ALT Position: Q1 2026 in Review

Russell Investments Group increased its Altimmune (ALT) stake by 11% in Q1 2026, buying an estimated $6.6K and bringing the position to 16,092 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

Russell Investments Group first reported a position in ALT in Q4 2016 and has held it in 15 quarters since. The position peaked at $695K in Q4 2016. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Russell Investments Group held 16,092 shares of Altimmune worth $49.6K as of Q1 2026.
  • Russell Investments Group bought 1,555 Altimmune shares in Q1 2026, an estimated $6.6K.
  • Altimmune made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3332 holding.
  • Russell Investments Group first reported a position in Altimmune in Q4 2016 and has held it in 15 quarters since.
  • Russell Investments Group's Altimmune position peaked at $695K in Q4 2016.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.